標題
返回
確定
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Topics
Business
Business
PR Newswire
AI & Semiconductor
AI & Semiconductor
Taiwan
Taiwan
Politics
Defense
Life
China
China
World
World
Editorial
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Business
AI & Semiconductor
Taiwan
China
World
Editorial
Home
Everest Medicines
#
Everest Medicines
About 3 search results
Sort by Date
Business
PR Newswire
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China
SHANGHAI
PR Newswire
2026-06-08 08:55
Everest Medicines
Corxel Pharmaceuticals
LNZ100
Business
PR Newswire
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market
SHANGHAI
PR Newswire
2026-06-04 18:32
Everest Medicines
Mabworks
Bejescin
Business
PR Newswire
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
SHANGHAI
PR Newswire
2026-06-02 20:27
Civorebrutinib
Everest Medicines
Travere Therapeutics